Alpha 2.0
Login Register
» Authors » Y Kanda

Y Kanda

Explore the profile of Y Kanda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 361
Citations 9018
Followers 0
Related Specialties
General Surgery
Oncology
Hematology
Top 10 Co-Authors
H Hirai
M Kami
S Chiba
Y Tanaka
Y Yazaki
T Saito
K Mitani
S Ogawa
S Kako
T Hamaki
Published In
Bone Marrow Transplant
Leuk Lymphoma
Gan To Kagaku Ryoho
Leukemia
J Biol Chem
Affiliations
Soon will be listed here.
Recent Articles
11.
Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma
Yano S, Mori T, Kanda Y, Kato J, Nakaseko C, Fujisawa S, et al.
Bone Marrow Transplant . 2015 Jul; 50(10):1299-305. PMID: 26168068
Allogeneic stem cell transplantation (allo-SCT) is a curative option for patients with relapsed follicular lymphoma (FL). Prospective studies of reduced-intensity conditioning (RIC) have revealed that chemosensitivity at allo-SCT is the...
12.
Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy
Tanaka M, Kanamori H, Matsumoto K, Tachibana T, Numata A, Ohashi K, et al.
Bone Marrow Transplant . 2015 Mar; 50(5):727-33. PMID: 25730191
This prospective study aimed to investigate the influence of pretransplant serum ferritin levels on the outcomes of allogeneic hematopoietic SCT (HSCT). In total, 190 patients with acute leukemia or myelodysplastic...
13.
Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation
Kikuchi M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, et al.
Transpl Infect Dis . 2015 Jan; 17(1):56-65. PMID: 25580541
Background: Bloodstream infections (BSI) are frequently observed after allogeneic hematopoietic stem cell transplant (HSCT), and could cause morbidity and mortality. Methods: We retrospectively evaluated the incidence, characteristics of, and risk...
14.
Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases
Kimura S, Murata T, Akahoshi Y, Nakano H, Ugai T, Wada H, et al.
Eur J Clin Microbiol Infect Dis . 2015 Jan; 34(5):951-61. PMID: 25577175
We compared the expected medical costs of empirical and preemptive treatment strategies for invasive fungal infection in neutropenic patients with hematological diseases. Based on the results of two clinical trials...
15.
Decision analysis for donor selection in stem cell transplantation-HLA-8/8 allele-matched unrelated donor vs HLA-1 AG mismatched related donor
Kanda J, Fuji S, Kato S, Takami A, Tanaka J, Miyamura K, et al.
Blood Cancer J . 2014 Dec; 4:e263. PMID: 25479570
Risk of relapse during the unrelated donor coordination period biases comparisons between allogeneic hematopoietic stem cell transplantation from an HLA 8 of 8 allele-matched unrelated donor (8/8 MUD) and that...
16.
Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation
Terasako-Saito K, Nakasone H, Tanaka Y, Yamazaki R, Sato M, Sakamoto K, et al.
Transpl Infect Dis . 2014 Nov; 16(6):930-40. PMID: 25430567
Background: Cytomegalovirus (CMV)-specific CD8(+) cytotoxic T lymphocytes (CMV-CTLs) play a crucial role in preventing CMV disease. However, the actual in vivo dynamics of CMV-CTL clones after allogeneic hematopoietic stem cell...
17.
Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation
Yamazaki R, Tanaka Y, Nakasone H, Sato M, Terasako-Saito K, Sakamoto K, et al.
Transpl Infect Dis . 2014 Nov; 16(6):904-13. PMID: 25367140
Background: Cytomegalovirus (CMV) reactivation still remains a major problem following allogeneic hematopoietic stem cell transplantation (HSCT). Patients And Methods: In this study, we analyzed an immunoglobulin allotype, IgG1m(f), in CMV-seropositive...
18.
Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT
Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, et al.
Bone Marrow Transplant . 2014 Jul; 49(9):1187-92. PMID: 25000457
In unrelated hematopoietic SCT (HSCT), HLA allele mismatch has been shown to have a significant role. To clarify the importance of HLA allele mismatch in the GVH direction in related...
19.
Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation
Sato M, Nakasone H, Terasako-Saito K, Sakamoto K, Yamazaki R, Tanaka Y, et al.
Bone Marrow Transplant . 2014 Jan; 49(4):553-60. PMID: 24419514
We previously reported that the baseline C-reactive protein level did not predict infectious events after hematopoietic cell transplantation (HCT). Procalcitonin (PCT) has recently emerged as a powerful biomarker for the...
20.
Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission
Tanaka J, Morishima Y, Takahashi Y, Yabe T, Oba K, Takahashi S, et al.
Blood Cancer J . 2013 Dec; 3:e164. PMID: 24292416
To clarify the effect of killer cell immunoglobulin-like receptor (KIR) ligand incompatibility on outcomes of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) patients in complete remission after single...